Glenmark Pharmaceuticals Limited (BOM:532296)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	170.43B	133.63B	126.45B	116.56B	123.05B
Total	170.43B	133.63B	126.45B	116.56B	123.05B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	37.24B	44.84B	33.97B	40.46B	43.81B
North America	71.39B	30.17B	30.94B	31.48B	32.04B
Europe	31.79B	30.06B	25.56B	20.06B	20.05B
Latin America and Rest of The World	29.40B	28.14B	27.67B	23.83B	-
Latin America	-	-	-	-	6.13B
Rest of The World (ROW)	-	-	-	-	21.03B
Total	169.83B	133.22B	118.13B	115.83B	123.05B

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error